Primary Peritoneal Carcinoma Withdrawn Phase 1 Trials for Acetylcysteine (DB06151)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01138137N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian CancerTreatment